Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis
type: MedicalStudy
description: Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE1
start date: 2005-11
end date: 2009-03
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00275613
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Mayo Clinic
study subject: Glomerulonephritis, Membranoproliferative
keywords: PHASE1
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Glomerulonephritis, Membranoproliferative

AI Analytics
type: Organization